The three-dimensionality of the hiPSC-CM spheroid contributes to the variability of the field potential.

Field potential (FP) signals from human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) spheroid which are used for drug safety tests in the preclinical stage are different from action potential (AP) signals and require working knowledge of the multi-electrode array (MEA) system. In this study, we developed three-dimensional (3-D) models of hiPSC-CM spheroids for the simulation of field potential measurement. We compared our model simulation results against experimental data under the effect of drugs E-4031 and nifedipine. 3-D models of hiPSC-CM spheroids were constructed in spherical and discoidal shapes. Tetrahedral meshes were generated inside the models, and the propagation of the action potential in the model was obtained by numerically solving the monodomain reaction-diffusion equation. An electrical model of electrode was constructed and FPs were calculated using the extracellular potentials from the AP propagations. The effects of drugs were simulated by matching the simulation results with experimental data. The simulated FPs from the 3-D models of hiPSC-CM spheroids exhibited highly variable shapes depending on the stimulation and measurement locations. The values of the IC of E-4031 and nifedipine calculated by matching the simulated FP durations with experimental data were in line with the experimentally measured ones reported in the literature. The 3-D models of hiPSC-CM spheroids generated highly variable FPs similar to those observed in experiments. The model has the potential to complement the interpretation of the FP signals obtained from experiments.